1. Evaluation Programs and Step Diversity
The architectural approach to evaluations differs significantly between these two firms, affecting how a trader manages risk and time.
- Maven’s Flexibility: Maven offers one of the most diverse ranges in the industry, including 1-Step, 2-Step, 3-Step, and Instant funding. The 3-Step program is particularly notable for having very low profit targets (3% per phase), which reduces the pressure for aggressive "home run" trades.
- DNA’s Specialized Phases: DNA provides 1-Phase, 2-Phase, and a unique Rapid Challenge. The Rapid Challenge imposes a 10-day time limit, a rare constraint in the current market, forcing traders into a high-activity environment that may not suit swing traders.
- Instant Funding Nuances: Both firms offer instant funding, but Maven’s "Mini" account acts as a high-speed, single-trade-focused entry point (24-hour duration), whereas DNA’s Instant Funding uses a progressive drawdown (4%) that increases as the account grows, rewarding sustained profitability rather than quick scalps.
2. Drawdown Mechanics and Risk Management
Understanding how drawdown is calculated is more important than the percentage itself, as it determines the actual "breathing room" of a strategy.
- Maven’s EOD vs. Trailing: Maven uses an EOD (End of Day) High-Watermark for daily drawdown on some accounts, which is generally more favorable than intraday equity trailing because it ignores temporary unrealized spikes. However, they use trailing drawdown for One-Step and Instant accounts, which "locks in" profits and makes it harder to recover after a winning streak.
- DNA’s Static Approach: DNA uses Static Drawdown for its evaluation phases (1-Phase, 2-Phase, and Rapid). This means the maximum loss limit is fixed at a percentage of the initial balance. This is objectively superior for traders as it allows them to keep the entirety of their earned buffer without the floor moving up behind them.
- Risk Limits: DNA imposes strict maximum exposure limits per symbol (e.g., 100 lots for Forex, 5 lots for BTC). Maven, conversely, focuses on a 1% floating PnL limit for Instant/Mini accounts, where the account is breached if equity drops 1% below balance at any time.
3. Trading Rules and Consistency Constraints
Both firms implement "soft" and "hard" rules that can impact payout eligibility without necessarily resulting in an account breach.
- News Trading: Both firms restrict trading during high-impact news. Maven uses a 4-minute window (2 minutes before/after), while DNA uses a 10-minute window (5 minutes before/after). DNA’s rule is stricter as it also applies to "market shocks" and unexpected events.
- The Consistency Test:
- Maven: Uses a 20% consistency rule for Instant/Mini accounts. Your largest winning day cannot exceed 20% of your total profit. If it does, you must continue trading until that percentage drops. This effectively forces a minimum of 5-10 active trading days.
- DNA: Uses a 40% daily profit cap during the funded phase. If you make more than 40% of your total withdrawal request in a single day, the excess is removed from the payout. Unlike Maven, this doesn't block the withdrawal, but it "trims" the profit.
- Algorithm Trading (EAs): This is a major differentiator. DNA permits EAs on its 1-Phase, 2-Phase, and Rapid challenges. Maven strictly prohibits EAs for autonomous trading, allowing them only as manual assistance tools.
4. Payout Structure and Financial Terms
- Payout Frequency: Maven allows payouts every 10 days. DNA’s standard is 14 trading days, though this can be reduced to 7 days if the trader purchases the "Early Payout" add-on.
- Profit Split: Both start at 80%. DNA allows an upgrade to 90% via a paid add-on, whereas Maven remains fixed at 80%.
- Withdrawal Caps: Maven imposes a $10,000 withdrawal cap per 30-day cycle. For high-capital traders, this is a significant bottleneck. DNA has a 5% profit cap on the first three payouts, but this cap is removed entirely after the third successful withdrawal.
- Fees: DNA charges a 1% fee for Crypto withdrawals and $50 for bank transfers. Maven’s payout fees are listed as UNKNOWN, but they utilize Rise and Crypto, which usually incur standard network/platform costs.
5. Technology, Platforms, and Assets
- Platform Selection: Maven is superior for platform-loyalists, offering MetaTrader 5, cTrader, and MatchTrader. DNA is restricted to TradeLocker, which is a more modern, web-based interface but lacks the deep ecosystem of MT5 or cTrader.
- Asset Classes: DNA offers a wider range of instruments by including Individual Stocks with 1:5 leverage. Maven focuses on the core quartet: Forex, Commodities, Indices, and Crypto.
- Leverage: Maven offers higher Forex leverage at 1:75, compared to DNA’s 1:50. This allows for higher margin efficiency but increases the risk of hitting the 1% floating loss rule on Maven's Instant accounts.
6. Summary: Which Firm to Choose?
Choose Maven if:
- You prefer using MetaTrader 5 or cTrader.
- You want a 3-Step evaluation with very low profit targets to minimize psychological stress.
- You are a manual trader who values higher leverage (1:75).
- You are interested in the Buyback feature, allowing you to bypass evaluations for a fee if you lose a funded account.
Choose DNA Funded if:
- You use Expert Advisors (EAs) or automated strategies.
- You prefer Static Drawdown, which provides a fairer environment for long-term growth.
- You want to trade Individual Stocks.
- You are a high-volume trader who wants to remove withdrawal caps after the initial three-payout "probation" period.
- You value "Add-ons" like the 90% profit share or the Reset Demo feature.
